Literature DB >> 20148371

ACE and ACTN3 genes and muscle phenotypes in nonagenarians.

N Bustamante-Ara1, C Santiago, Z Verde, T Yvert, F Gómez-Gallego, G Rodríguez-Romo, P González-Gil, J A Serra-Rexach, J R Ruiz, A Lucia.   

Abstract

We studied the association of ACE and ACTN3 polymorphisms with skeletal muscle phenotypes (i. e. upper and lower body muscular strength and functional tests) in Spanish nonagenarian subjects [n=41, 33 women, 8 men, age: 90-97 years]. Mean values of the study phenotypes were not significantly different (all P>0.05) between ACE and ACTN3 genotypes. The analyses of the combined effects between genotypes ( ACE DD & ACTN3 RR/RX vs. ACE II/ID & ACTN3 XX) did not yield any significant difference. Our data suggest that, in the elderly, the influence of genetic factors on muscle phenotype traits is not reducible to a few single polymorphisms, including ACE and ACTN3 variants. Copyright Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148371     DOI: 10.1055/s-0030-1247529

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  16 in total

Review 1.  Advances in exercise, fitness, and performance genomics in 2010.

Authors:  James M Hagberg; Tuomo Rankinen; Ruth J F Loos; Louis Pérusse; Stephen M Roth; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2011-05       Impact factor: 5.411

Review 2.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 3.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 4.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

5.  Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults?

Authors:  Gabriel Rodríguez-Romo; Jonatan R Ruiz; Catalina Santiago; Carmen Fiuza-Luces; Marta González-Freire; Félix Gómez-Gallego; María Morán; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2010-08-24       Impact factor: 3.078

6.  Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians.

Authors:  Nuria Garatachea; Carmen Fiuza-Luces; Gema Torres-Luque; Thomas Yvert; Catalina Santiago; Félix Gómez-Gallego; Jonatan R Ruiz; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2011-11-02       Impact factor: 3.078

7.  ACE I/D and ACTN3 R/X polymorphisms as potential factors in modulating exercise-related phenotypes in older women in response to a muscle power training stimuli.

Authors:  Ana Pereira; Aldo M Costa; Mikel Izquierdo; António J Silva; Estela Bastos; Mário C Marques
Journal:  Age (Dordr)       Date:  2012-08-02

8.  Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism.

Authors:  Carmen Fiuza-Luces; Jonatan R Ruiz; Gabriel Rodríguez-Romo; Catalina Santiago; Félix Gómez-Gallego; Thomas Yvert; Amalia Cano-Nieto; Nuria Garatachea; María Morán; Alejandro Lucia
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

9.  Association of Angiotensin Converting Enzyme I/D and α-actinin-3 R577X Genotypes with Growth Factors and Physical Fitness in Korean Children.

Authors:  Kijin Kim; Nayoung Ahn; Wookwang Cheun; Jayoung Byun; Youngsik Joo
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

10.  ACE and UCP2 gene polymorphisms and their association with baseline and exercise-related changes in the functional performance of older adults.

Authors:  Justin W L Keogh; Barry R Palmer; Denise Taylor; Andrew E Kilding
Journal:  PeerJ       Date:  2015-05-28       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.